XML 30 R18.htm IDEA: XBRL DOCUMENT
v3.25.1

RESTRUCTURING, ASSET IMPAIRMENTS, AND OTHER CHARGES | 3 Months Ended
--- | ---
Mar. 31, 2025
RESTRUCTURING, ASSET IMPAIRMENTS, AND OTHER CHARGES |
RESTRUCTURING, ASSET IMPAIRMENTS, AND OTHER CHARGES | NOTE 10. RESTRUCTURING, ASSET IMPAIRMENTS, AND OTHER CHARGES Details of restructuring, asset impairments, and other charges are as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended March 31, | ​
​ | ​ | 2025 | ​ | 2024 |
​ | ​ | (in millions) | ​
Restructuring |  | $ | 0.6 | ​ | $ | — | ​
Other charges | ​ | ​ | 0.6 | ​ | ​ | 0.2 | ​
Total restructuring, asset impairments, and other charges | ​ | $ | 1.2 |  | $ | 0.2 |
​ Restructuring We have the following restructuring plans in process: 2024 Plan On July 29, 2024, we approved actions in furtherance of our manufacturing consolidation initiatives intended to optimize our manufacturing footprint and cost structure, including the closure of our Zhongshan, China manufacturing facility (the “2024 Plan”). The amounts incurred as a result of the approved actions are estimates and actual results may differ, which could result in incremental restructuring charges in future periods. We anticipate the 2024 Plan will be substantially completed by the end of the second quarter of 2025, with final activities expected to conclude in 2026. 2023 Plan In 2023, we approved a plan intended to optimize and further consolidate our manufacturing operations and functional support groups as well as a general reduction-in-force to align our expenses to revenue levels (the “2023 Plan”). We expect to incur approximately $1.0 million in additional charges through the second quarter of 2026. The 2023 Plan is substantially complete, with the final activities expected to conclude in 2026. Changes in restructuring liabilities were as follows: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | 2024 Plan |  | 2023 Plan |  | Total
​ | ​ | (in millions)
December 31, 2024 | ​ | $ | 25.0 | ​ | $ | 5.0 | ​ | $ | 30.0
Severance costs incurred and charged to expense | ​ | ​ | 0.6 | ​ | ​ | — | ​ | ​ | 0.6
Costs paid | ​ | ​ | (2.9) | ​ | ​ | (0.8) | ​ | ​ | (3.7)
March 31, 2025 | ​ | $ | 22.7 | ​ | $ | 4.2 | ​ | $ | 26.9
​ The above restructuring liability of $26.9 million is comprised of $24.4 million in other accrued expenses and $2.5 million included in other long-term liabilities on our Consolidated Balance Sheets. ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Cumulative Cost Through
​ | ​ | March 31, 2025
​ |  | 2024 Plan |  | 2023 Plan |  | Total
​ | ​ | (in millions)
Severance and related charges |  | $ | 30.2 | ​ | $ | 15.4 | ​ | $ | 45.6
Facility relocation and closure charges | ​ | ​ | 0.1 | ​ | ​ | — | ​ | ​ | 0.1
Total restructuring charges | ​ | $ | 30.3 | ​ | $ | 15.4 | ​ | $ | 45.7
​ Other Charges Other charges relate to vacating and relocating facilities.

X
- References No definition available. + Details
Name: | us-gaap_RestructuringCostsAndAssetImpairmentChargesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets. + References No definition available. + Details
Name: | us-gaap_RestructuringImpairmentAndOtherActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration